Myopia Management
Independent medical education supported by EssilorLuxottica, Hoya, Cooper Vision
Videos
IME Webinar Series #1
Comprehensive Update on Myopia Management - Q&A Session
Symposium Part #1:
Comprehensive Update on Myopia Management
Symposium Part #2:
Comprehensive Update on Myopia Management
Interview 1:
Patient education and
genetic risk factors
Interview 2:
Balancing the use of spectacles, contact lenses, and pharmaceuticals
Interview 3:
Behavioral modification
and other considerations
Podcasts
Podcasts
Episode 1:
Patient education and
genetic risk factors
In this episode of the WSPOS podcast series on Myopia Management, Dr. Ken Nischal and Ms. Hannah Scanga discuss the myopia epidemic, potential underlying genetic risk factors and how to educate patients and the community about it. To hear the entire interview, make sure to listen the remaining two episodes in this series.
Independent Medical Education supported by EssilorLuxottica (Gold), Hoya (Silver), Cooper Vision (Bronze).
Podcasts
Episode 2:
Balancing the use of spectacles,
contact lenses, and pharmaceuticals
In this episode of the WSPOS podcast series on Myopia Management, Dr. Ken Nischal and Ms. Hannah Scanga review various currently available treatment options to manage myopia progression. To hear the entire interview, make sure to listen the remaining two episodes in this series.
Independent Medical Education supported by EssilorLuxottica (Gold), Hoya (Silver), Cooper Vision (Bronze).
Podcasts
Episode 3:
Behavioral modification and
other considerations
In this episode of the WSPOS podcast series on Myopia Management, Dr. Ken Nischal and Ms. Hannah Scanga speak about the importance of behavioral modification in the management of myopia patients and other considerations. To hear the entire interview, make sure to listen the remaining two episodes in this series.
Independent Medical Education supported by EssilorLuxottica (Gold), Hoya (Silver), Cooper Vision (Bronze).
Supplements (Coming Soon)
eLearning
The Global Myopia Epidemic & Its Clinical Consequences
This independent medical education elearning content is supported by EssilorLuxottica, Hoya, and Cooper Vision.
This content has been developed to help you better understand the global myopia epidemic, and its causes, as well as the clinical implications of high myopia for you as a clinician and your patients.
The Clinical Impact of Myopia
& First Line Treatment
This independent medical education elearning content is supported by EssilorLuxottica, Hoya, and Cooper Vision.
This content has been developed to help you better understand the clinical impact of myopia – the considerations for patients, parents and you; and also to help you explore behaviour modification as the first-line treatment in myopia.
